Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of a new complement-dependent lymphocytotoxicity cross match method using an automated cell counter, the NucleoCounter® NC-3000™.

HLA - 1 Jun 2023

Pedini Pascal, Baudey Jean-Baptiste, Basire Agnès, Chiaroni Jacques, Hubert Lucas, Picard Christophe

Abstract excerpt

Complement-dependent lymphocytotoxicity cross match (CDC-XM) is the ultimate test of donor/recipient compatibility prior to organ transplantation. This test is based on cell viability, evaluated under fluorescence microscopy by an operator after proper staining. The determination of the positivity threshold may vary depending on the operator. We developed a new method in which the final step of determining cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Grouping and Crossmatching
Share to Complement System Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Graft Rejection

Share to Histocompatibility Testing

Share to HLA Antigens

Share to Isoantibodies

Share to Kidney Transplantation

Share to Organ Transplantation

Source

Identifiers

PMID: 37015889
DOI: 10.1111/tan.15044

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of a new complement-dependent lymphocytotoxicity cross match method using an automated cell counter, the NucleoCounter® NC-3000™.PMID 37015889Read ↗

Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.Semantic proximity Read ↗

Initial results of Central European Immunophenotyping Quality Control Program (CEQUAL).Semantic proximity Read ↗

New methods for the quantification of mixed chimerism in transplantationSemantic proximity Read ↗

Systematic Comparison of Four Cell- and Luminex-Based Methods for Assessment of Complement-Activating HLA AntibodiesSemantic proximity Read ↗

Evaluation of a Novel Mononuclear Cell Isolation Procedure for Serological HLA TypingSemantic proximity Read ↗

Validation of cytomegalovirus immune competence assays for the characterization of CD8(+) T cell responses posttransplant.Semantic proximity Read ↗

Enumeration of Nucleated Red Blood Cells with the ADVIA 2120 Hematology System: An International Multicenter Clinical TrialSemantic proximity Read ↗

Root cause analysis of limitations of virtual crossmatch for kidney allocation to highly-sensitized patients.Semantic proximity Read ↗

Review article: Luminex technology for HLA antibody detection in organ transplantation.Semantic proximity Read ↗

Detection of Anti-Non-α-Gal Xenoreactive Antibodies in Human Blood ProductsSemantic proximity Read ↗

A one-step assay for sorted CD3+ cell purity and chimerism after hematopoietic stem cell transplantation.Semantic proximity Read ↗

Inter-individual differences in HLA expression can impact the CDC crossmatch.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.